DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

Illumina (NASDAQ: ILMN)

217.27 -3.83 (-1.73%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ILMN $217.27 -1.73%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $218.92
Previous Close $221.10
Daily Range $214.01 - $219.40
52-Week Range $145.12 - $242.37
Market Cap $31.3B
P/E Ratio 74.19
Dividend (Yield) $0.00 (0.0%)
Volume 1,488,788
Average Daily Volume 1,601,974
Current FY EPS $3.45




Drug Makers

Illumina (ILMN) Description

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Website:

News & Commentary Rss Feed

3 Signs That the Healthcare Stock Bubble Might Have Just Popped

Should healthcare investors start to move to the sidelines after the disappointing earnings reports from top dogs AbbVie, Biogen, and Illumina?

Illumina: Unchanged Confidence In The Long-Term Outlook

Biotech ETFs: 3 Questions For IShares Investing Expert

Why Earnings Season Should Matter To ETF Investors

Apple and 3 Other Stocks with Major Price Changes Post-Earnings - Stocks in the News

Illumina Tops Q2 Earnings, Misses on Revenues; EPS View Up - Analyst Blog

Illumina Gets a Reset

Why Illumina Inc. Stock Sank Like a Stone Today

Shares of the gene-sequencing giant Illumina fell by 11% today. Here's why.

Illumina (ILMN) Stock Falls After Reporting Earnings Results

Morning Market Losers

See More ILMN News...

ILMN's Top Competitors

ILMN $217.27 (-1.73%)
Current stock: ILMN
TMO $137.02 (-0.67%)
Current stock: TMO
$0.00 (0.00%)
Current stock:
QGEN $27.10 (-1.56%)
Current stock: QGEN